Research and clinical development
Practice external collaboration without exposing participant data, unpublished findings, protocols, compounds, or controlled information.
Pharmaceutical companies connect research, clinical development, manufacturing, quality, regulatory, supply chain, commercial operations, and external partners across sensitive workflows.
A responsible simulation should practice workforce verification without exposing patient, trial, product, quality, regulatory, or intellectual-property information—or interacting with validated and production systems.
Care-aware planning • Fictional scenarios • Privacy boundaries • Practical reporting
Start with the workforce, systems, and verification routes involved in the selected workflow. The exercise must remain secondary to patient care, safety, product quality, and real incident response.
Practice external collaboration without exposing participant data, unpublished findings, protocols, compounds, or controlled information.
Use neutral workforce scenarios outside production, laboratory, batch, deviation, release, and quality-management systems.
Avoid messages that resemble active submissions, inspections, adverse-event reports, recalls, or authority communications.
Reinforce independent verification for suppliers, logistics, payments, portals, contracts, and shared documents using fictional business data.
Give the scenario one learning objective and one explainable next step. Use fictional people and records, and avoid urgent clinical, patient, safety, recall, or public-health themes.
Ask employees to validate an invented researcher, organization, project, access request, and destination.
Practice reaching the known supplier or quality service independently using fictional product and company details.
Reinforce checking the organizer, event, destination, requested information, and payment route before responding.
Ask employees to use the authentic identity or support route rather than an unexpected sign-in page.
| Consideration | Question to answer | Required preparation |
|---|---|---|
| Sensitive information | Could the scenario expose patient, trial, product, research, quality, regulatory, or commercial information? | Use entirely fictional details and obtain the appropriate data-owner and specialist review. |
| System separation | Can any campaign action reach a laboratory, validated, production, quality, safety, or regulatory system? | Use isolated training destinations and prohibit production credentials, integrations, records, and changes. |
| Operational signals | Could the message be mistaken for a deviation, inspection, recall, shortage, safety event, or product issue? | Exclude consequential themes and check active operational events immediately before launch. |
| Global scope | Do region, language, law, works council, support, or partner conditions differ? | Complete applicable review, localize and pilot content, and document conditions for each population. |
State the request being tested, the expected verification or reporting action, the authorized workforce group, and how observations will be used.
Document exclusions, data boundaries, operational approvers, delivery windows, escalation contacts, and conditions that require the campaign to stop.
Test representative accounts, shifts, devices, accessibility tools, email controls, landing pages, event records, reporting routes, and follow-up material.
Prepare security, IT, privacy, clinical or operational leadership, communications, and relevant providers while preserving normal handling of real reports.
Explain the expected action, provide relevant private learning, and assign every workflow or control improvement to a responsible owner.
Record intended recipients, exclusions, successful deliveries, unique recipient events, verified reports, response handling, and completed follow-up. Reconcile automated link inspection and repeated events before attributing an action to a person.
Compare like audiences and scenarios, documenting region, language, role, device, partner status, delivery, support, and operational context. Global or function-wide percentages can conceal materially different conditions.
Use findings to improve reporting, verification, identity, email, access, vendor, or support processes. A simulation observes a limited interaction; it does not measure clinical competence, overall workforce risk, or regulatory compliance.
Common questions about Phishmake's features, onboarding, and support, answered to help you get started with confidence.
Avoid recall, adverse-event, inspection, shortage, trial-safety, and product-quality themes. They can trigger consequential action and undermine trusted regulated communications.
No. Use invented organizations, studies, products, batches, participants, results, and documents. The learning objective should not require sensitive or regulated information.
Only when the request, expected action, systems, support, and context genuinely apply to both. Different functions commonly need separate scopes and specialist review.
No. A workforce simulation is not system validation and does not establish product, quality, privacy, security, or regulatory compliance.
Explore how Phishmake connects controlled workforce simulations, relevant training, campaign activity, and follow-up reporting in one workflow.